2407 |
Feasibility and Risk of PMVSD Closure: Who Are Good Candidates for Device Closure |
Bharat Dalvi |
May. 14. 13 |
2406 |
Aortic Rim Deficiency and Erosion After ASD Closure: A Gossip or Fact? |
Ziyad M. Hijazi |
May. 14. 13 |
2405 |
Clinical Trials for PFO Closure: Lessons Learnt and Future Perspectives |
Horst Sievert |
May. 14. 13 |
2404 |
Transcatheter Closure of Collaterals and Fistulae: Coils Vascular Plugs and Others |
Jou-Kou Wang |
May. 14. 13 |
2403 |
Mild Resistant Hypertension with Renal Denervation in Korea |
Seung Hyuk Choi |
May. 14. 13 |
2402 |
Challenging Anatomies and Situations |
Horst Sievert |
May. 14. 13 |
2401 |
Appropriate Patient Selection for Renal Denervation |
Byeong-Keuk Kim |
May. 14. 13 |
2400 |
Future Direction of Renal Denervation |
Paul A. Sobotka |
May. 14. 13 |
2399 |
Possible Role of Rivaroxaban in ACS Patients: Lessions Learned from ATLAS ACS 2 TIMI 51 |
Freek W.A. Verheugt |
May. 14. 13 |
2398 |
Who Will Get the Greatest Benefit from New DAPT?: Indirect Comparison Between Prasugrel and Ticagrelor |
Seung-Jin Oh |
May. 14. 13 |